AgeX Therapeutics (AGE) News Today → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free AGE Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSerina Therapeutics Announces Completion of Merger with AgeX Therapeuticsglobenewswire.com - March 26 at 5:04 PMAgeX Therapeutics, Inc.: AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Resultsfinanznachrichten.de - March 23 at 10:09 AMAgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Resultsglobenewswire.com - March 22 at 5:27 PMAgeX Therapeutics (NYSE:AGE) Sees Unusually-High Trading Volumemarketbeat.com - March 18 at 4:04 PMAgeX Therapeutics (NYSE:AGE) Reaches New 12-Month High at $17.42marketbeat.com - March 15 at 1:47 PMAGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGEbusinesswire.com - February 27 at 3:19 PMAgeX Therapeutics Secures $500K Convertible Note Dealmsn.com - February 7 at 9:02 AMAgeX Therapeutics Expands Ties with JuvVentures Equity Dealmsn.com - February 7 at 9:02 AMWhy IBM Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarketmsn.com - January 25 at 12:09 PMAgeX Therapeutics Inc AGEmorningstar.com - December 13 at 3:40 PMWhat's Going On With Penny Stock AgeX Therapeutics?msn.com - November 17 at 5:51 PMSerina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizerfinance.yahoo.com - November 17 at 12:50 PMAgeX Therapeutics GAAP EPS of -$0.14, revenue of $0.06Mmsn.com - November 14 at 8:14 PMAgeX Therapeutics Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 14 at 8:14 PMObesity Pipeline | Clinical Trials, Key Companies – Aardvark, Adocia, Agentix AgeX Therapeuticsbenzinga.com - November 6 at 8:13 PMSerina Therapeutics to merge with subsidiary of AgeXmsn.com - August 31 at 8:46 AMShareholder Alert: Ademi LLP investigates whether AgeX Therapeutics, Inc. has obtained a Fair Price in its transaction with Serinabenzinga.com - August 30 at 10:45 PMSerina Therapeutics and Agex Therapeutics enter merger agreementseekingalpha.com - August 30 at 5:44 PMAgeX Therapeutics Shares Rise Premarket on Reverse Merger Deal >AGEmarketwatch.com - August 30 at 5:44 PMSerina Therapeutics and AgeX Therapeutics Enter into Merger Agreementfinance.yahoo.com - August 30 at 5:44 PMAgeX Therapeutics Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 14 at 5:43 PMAgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stockfinance.yahoo.com - July 24 at 7:04 PMAgeX issues preferred stock to Juvenescence to nix $36M debtseekingalpha.com - July 21 at 6:10 PM25 States with the Highest Life Expectancy in the USfinance.yahoo.com - June 28 at 8:18 PMNYSE American to Suspend Trading Immediately in AgeX Therapeutics, Inc. (AGE) and Commence Delisting Proceedingsfinance.yahoo.com - May 17 at 7:03 PMCORRECTING and REPLACING NYSE American to Commence Delisting Proceedings Against AgeX Therapeutics, Inc. (AGE)businesswire.com - May 17 at 7:03 PMAgeX Therapeutics GAAP EPS of -$0.09, revenue of $0.01Mseekingalpha.com - May 12 at 8:07 PMAgeX Therapeutics Says Projected Cash Flows Raise Going Concern Doubtsmarketwatch.com - May 12 at 8:07 PMAgeX Therapeutics Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 12 at 8:07 PMAgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Resultsfinance.yahoo.com - March 31 at 4:45 PMAGE AgeX Therapeutics, Inc.seekingalpha.com - March 30 at 5:30 PMTonix starts enrollment in mid-stage study of depression drug TNX-601 ERmsn.com - March 16 at 8:05 AMAgeX Therapeutics gets $10M loan ahead of potential restructuringmsn.com - March 16 at 8:05 AMJuvenescence Now Owns 75.60% of AgeX Therapeutics247wallst.com - February 21 at 1:32 PMAnti-Senescence Therapy Market Industry Analysis Database for Period from 2023-2028marketwatch.com - February 13 at 6:31 PMWith 7.8% CAGR, Longevity and Anti-senescence Therapy Market to Witness A Pronounce Growth During 2023-2028 | 87 Pages Reportmarketwatch.com - December 22 at 8:57 AMLongevity and Anti-senescence Therapy Market 2023 Expected to Reach Significant Rate by 2028marketwatch.com - December 2 at 2:51 AMAgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirementsfinance.yahoo.com - November 25 at 3:52 PMAgeX Therapeutics Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 10 at 4:54 PMLongevity and Anti-senescence Therapy Market Analysis Research Report, Challenges, Scopes, Market Share, Revenue, and Forecasts 2022 to 2028marketwatch.com - October 12 at 4:23 AMAgeX Therapeutics, Inc. (AGE)finance.yahoo.com - September 12 at 1:14 PMAgeX Therapeutics GAAP EPS of -$0.07, revenue of $0.01Mseekingalpha.com - August 14 at 7:21 PMAgeX Therapeutics Says Its Cash Position Raises Doubt About Continuing as a Going Concernmarketwatch.com - August 14 at 7:21 PMAgeX Therapeutics Reports Second Quarter 2022 Financial Resultsfinance.yahoo.com - August 12 at 4:39 PMThe 9th ARDD: Longevity Biotechnology Is Gaining Prominence And Credibility In The Pharmaceutical Industryforbes.com - August 11 at 3:22 PMDr. Joanne Hackett Appointed Chairperson of AgeX Board of Directorsfinance.yahoo.com - May 18 at 1:20 PMAgeX Therapeutics GAAP EPS of -$0.07seekingalpha.com - May 15 at 10:15 PMAgeX Therapeutics Reports First Quarter 2022 Financial Resultsfinance.yahoo.com - May 13 at 6:38 PMGlobal Senolytic Drugs Market, By Type, By Application, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2017-2027uk.finance.yahoo.com - April 14 at 4:19 AMAgeX Therapeutics GAAP EPS of -$0.23, revenue of $0.14Mseekingalpha.com - March 31 at 10:00 PM Get AgeX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now AGE Media Mentions By Week AGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGE News Sentiment▼0.000.42▲Average Medical News Sentiment AGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGE Articles This Week▼00▲AGE Articles Average Week Get AgeX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ELAB News AKTX News IMNN News MNPR News MIRA News MBRX News RDHL News PPBT News MTEM News ABVC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AGE) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldThe only AI company you should be looking atBehind the MarketsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AgeX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
